Insider Ledger
PepGen Inc. (PEPG) insider buying and SEC filings
PepGen Inc. · CIK 1835597
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$59K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| May 21, 2026 | Planned (10b5-1) | Kasra Kasraian (Chief Technical Officer) sold 1,233 shares at about $1.41 ($2K), marked as a 10b5-1 plan trade. Holdings down 2% to 50,074 shares. | SEC filing Filed May 26, 2026 |
| Mar 4, 2026 | Planned (10b5-1) | Paul Streck (EVP, Head of R&D) sold 1,879 shares at about $6.23 ($12K), marked as a 10b5-1 plan trade. Holdings down 2% to 76,226 shares. | SEC filing Filed Mar 6, 2026 |
| Mar 4, 2026 | Planned (10b5-1) | Noel Donnelly (CFO) sold 2,084 shares at about $6.23 ($13K), marked as a 10b5-1 plan trade. Holdings down 2% to 111,603 shares. | SEC filing Filed Mar 6, 2026 |
| Mar 4, 2026 | Planned (10b5-1) | James G McArthur (CEO and Director) sold 5,275 shares at about $6.23 ($33K), marked as a 10b5-1 plan trade. Holdings down 2% to 296,326 shares. | SEC filing Filed Mar 6, 2026 |
17 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow PEPG in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.